Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (990) Neurology and Neurosciences (402) Clinical Cancer Research (261) Prostate Cancer (85) Chemotherapy and Side Effects Management (153) Urology (69) Clinical Trials and Protocols in Perioperative Medicine (38)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/97886, first published .
Doctor reassures concerned senior man about joint pain in clinic

Neoadjuvant Apalutamide With or Without Abiraterone Acetate Plus Prednisone and Gonadotropin-Releasing Hormone Agonist Prior to Nerve-Sparing Radical Prostatectomy in High-Risk Prostate Cancer: Protocol for a Randomized Phase 2 Trial

Neoadjuvant Apalutamide With or Without Abiraterone Acetate Plus Prednisone and Gonadotropin-Releasing Hormone Agonist Prior to Nerve-Sparing Radical Prostatectomy in High-Risk Prostate Cancer: Protocol for a Randomized Phase 2 Trial

Authors of this article:

Anthony Y Zhang1 Author Orcid Image ;   Mark N Stein2 Author Orcid Image ;   Saum Ghodoussipour3 Author Orcid Image ;   Isaac Y Kim1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Altmetric

Altmetric discovers Social Media mentions. Click the ‘See more details’ link for a full report.

Dimensions

Dimensions discovers Citations. Click the ‘details’ link for a full report.

Metrics Since Publication

Download .csv
Daily | Monthly | Annually